Lei Fan

26PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersRadiation therapyMedical biotechnology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 28, 2026
Unveiling the Prognostic Power of Circulating Tumor DNA in Multiple Myeloma: A Systematic Review and Updated Meta-Analysis.

|Jul 16, 2026
Dose-reduced (24 Gy) involved-site radiotherapy combined with rituximab in early-stage non-gastric mucosa-associated lymphoid tissue lymphoma: a prospective phase II trial.

|Apr 26, 2026
Outcomes With First-Line PD1 Inhibitors in Extranodal NK/T-Cell Lymphoma: A Comparative Analysis From a 755-Patient Multicenter Cohort.

|Mar 09, 2026
A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia.

Yi Xia, Haorui Shen, Yi Miao

|Jan 21, 2026
Efficacy and safety of selinexor combined with VRD in newly diagnosed multiple myeloma with EMD: a phase 2 trial.

Yuanyuan Jin, Xin Cheng, Xuezhong Zhang

|Dec 19, 2025
Preclinical evaluation of TIGIT as a target to enhance efficacy and mitigate T cell exhaustion in multiple myeloma following BCMA-CAR-T therapy.

Yuan Xia, Jianfeng Zhu, Rui Guo

Pageof 5

Frequent Collaborators

12 joint publications

Jianyong Li

6 joint publications

Yi Miao

3 joint publications

Wei Xu

3 joint publications

Huayuan Zhu